Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
Cancer Letters · 2024-05 · 590 · 216856
DOI: 10.1016/j.canlet.2024.216856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024-05. Verfasst von Qiang Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China. Hauptthemen laut MEDLINE: Neoplasms, Autophagy, Immunotherapy. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 377 Literaturangaben. Gefördert von: Air Force Medical University.
Abstract (Originalsprache)
Both the innate and adaptive immune systems work together to produce immunity. Cancer immunotherapy is a novel approach to tumor suppression that has arisen in response to the ineffectiveness of traditional treatments like radiation and chemotherapy. On the other hand, immune evasion can diminish immunotherapy's efficacy. There has been a lot of focus in recent years on autophagy and other underlying mechanisms that impact the possibility of cancer immunotherapy. The primary feature of autophagy is the synthesis of autophagosomes, which engulf cytoplasmic components and destroy them by lysosomal degradation. The planned cell death mechanism known as autophagy can have opposite effects on carcinogenesis, either increasing or decreasing it. It is autophagy's job to maintain the balance and proper functioning of immune cells like B cells, T cells, and others. In addition, autophagy controls whether macrophages adopt the immunomodulatory M1 or M2 phenotype. The ability of autophagy to control the innate and adaptive immune systems is noteworthy. Interleukins and chemokines are immunological checkpoint chemicals that autophagy regulates. Reducing antigen presentation to induce immunological tolerance is another mechanism by which autophagy promotes cancer survival. Therefore, targeting autophagy is of importance for enhancing potential of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China.
- Department of Thyroid, Breast and Vascular Surgery, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China.
- Department of Digestive Surgery, Xijing Hospital, Air Force Medical University, Xi'an, 710032, China. Electronic address: liyunlong1213@163.com.
Förderung
- Air Force Medical University
Zitieren
APA
Yu, Q., Ding, J., Li, S., & Li, Y. (2024). Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions. Cancer Letters, 590, 216856. https://doi.org/10.1016/j.canlet.2024.216856
Vancouver
Yu Q, Ding J, Li S, Li Y. Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions. Cancer Letters. 2024;590:216856. doi:10.1016/j.canlet.2024.216856
BibTeX
@article{Yu2024,
author = {Yu, Qiang and Ding, Jiajun and Li, Shisen and Li, Yunlong},
title = {Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions},
journal = {Cancer Letters},
year = {2024},
volume = {590},
pages = {216856},
doi = {10.1016/j.canlet.2024.216856}
}
EUVIMED